Pharmacoepidemiology, as an interdisciplinary domain amalgamating pharmacology and epidemiology, is dedicated to scrutinizing the real-world ramifications of pharmaceuticals within populations. Employing observational research methodologies and scrutinizing extensive datasets, pharmacoepidemiologists discern intricate patterns concerning drug employment, adverse effects, and therapeutic consequences. A pivotal objective is the provision of evidence-based insights tailored for healthcare practitioners, policymakers, and the pharmaceutical sector. This, in turn, shapes decisions regarding drug prescription practices, regulatory measures, and public health strategies. Pharmacoepidemiological inquiries incorporate diverse study designs, encompassing cohort studies and case-control analyses, to meticulously explore outcomes related to drug usage.
The field continually evolves to surmount challenges inherent in addressing confounding variables and biases during the phases of data collection, analysis, and interpretation. The accrued insights play a pivotal role in the continual refinement of clinical guidelines and the vigilance inherent in drug safety monitoring protocols.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia